A few weeks back, I wrote a post about why pharma and healthcare companies need to consider adding product reviews to their sites. For those of you who didn’t read that article and thus are completely up in arms that I would suggest this, please take a look at my original article before you decide. You’ll see that I’m readily acknowledging that adding ratings and reviews to a brand site wouldn’t be simple and isn’t without its regulatory risks, but I am trying to argue that the benefits just might outweigh the risks.
This is a teaser of One More Reason Pharma Needs Product Reviews
. Click here to read the full post: (1503 words, 2 images, ~6:01 minutes reading time)
A few weeks ago I submitted an article to iMedia Connection that I originally wrote for this blog. However, I couldn’t really figure out a solid pharma and/or healthcare angle, so I sent it to them to see if they were interested. They were. As you know, I just started writing a blog for iMedia Connection. I’m including stories there that aren’t really healthcare specific, but I’m also including a link from this blog because I think they are still interesting for most of Dose of Digital’s readers. (PS: Thanks to all of you who read the Twitter article I wrote. It’s still the most popular blog post on iMedia.)
This is a teaser of 4 Technologies That Are Killing the URL
. Click here to read the full post: (263 words, 1 image, ~1:03 minutes reading time)
Yesterday, I had the chance to speak at the Business Development Institute’s Social Communications & Healthcare Case Studies and Roundtables Conference. It was a well-done conference with about 350 people in attendance, which is a pretty big number these days. I also got to meet in person some of my Twitter friends, which was great.
Speaking of Twitter, there was quite a bit of participation during the conference and you can run through the entire stream. You can search for #bdi or review it all in real time here.
This is a teaser of Greetings from the Business Development Institute Conference
. Click here to read the full post: (833 words, 2 images, ~3:20 minutes reading time)
That’s right. I know a little bit more about digital than what’s happening in pharma. Since I know the audience here really likes to tackle pharma and healthcare-specific issues, I haven’t really posted any general digital commentary. I may in the future (let me know your thoughts in the comments), but for now, we’ll stay focused.
Since I do have a bunch to say about digital in other industries, I needed a new venue. The people at iMedia Connection just gave me one. They’ve taken me on as one of their bloggers. If you visit my blog there, you’ll see some more of my thinking on general digital issues that aren’t directly relevant to pharma. You might just pick up a few things you can use.
This is a teaser of More Digital Insights (Now with LESS Pharma)
. Click here to read the full post: (284 words, 1 image, ~1:08 minutes reading time)
I just couldn’t resist this post title after the response I had to my post (both positive and negative) called: What Pharma Can Learn from Pringles. Without going into too much detail, the takeaway message was supposed to be simple. Pharma and healthcare can learn a lot about the approaches other industries take in their marketing. Yes, pharma in particular is heavily regulated and limited in what they can do or say, but too often the best practices of other industries are ignored instead of us figuring out how to apply what worked well elsewhere to what we’re doing in pharma. It’s a big missed opportunity that I’ve been working on fixing for a long time.
This is a teaser of What Pharma Can Learn from the Pizza Guy
. Click here to read the full post: (1632 words, 3 images, ~6:32 minutes reading time)
